Mcglynn Margaret G insider trades
Mcglynn Margaret G has filed 21 Form 4s with the SEC that we hold, for FOLD (Director), Novavax INC (NVAX) (Director) and Vertex Pharmaceuticals INC / Ma (VRTX) (Director). Across all of them we count 0 purchases worth $0 and 13 sales worth $4.4M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 4,900 shares of Vertex Pharmaceuticals INC / Ma worth $1.4M, dated 2022-04-08. The first filing on our record is dated 2022-02-01 and the latest 2026-06-23.
FOLD
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-02 | S, sale reported on Form 4 | 15,000 | $104.8K | 2022-05-04 |
| 2023-01-13 | S, sale reported on Form 4 | 15,000 | $195.4K | 2023-01-17 |
| 2024-03-04 | S, sale reported on Form 4 | 7,500 | $99.7K | 2024-03-06 |
| 2024-03-05 | S, sale reported on Form 4 | 7,500 | $100.5K | 2024-03-06 |
Novavax INC (NVAX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Vertex Pharmaceuticals INC / Ma (VRTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-28 | S, sale reported on Form 4 | 800 | $193.5K | 2022-02-01 |
| 2022-01-28 | S, sale reported on Form 4 | 212 | $51.6K | 2022-02-01 |
| 2022-01-28 | S, sale reported on Form 4 | 2,087 | $506.7K | 2022-02-01 |
| 2022-01-28 | S, sale reported on Form 4 | 1,901 | $457.2K | 2022-02-01 |
| 2022-03-31 | S, sale reported on Form 4 | 1,011 | $265.9K | 2022-04-04 |
| 2022-03-31 | S, sale reported on Form 4 | 2,970 | $779.2K | 2022-04-04 |
| 2022-03-31 | S, sale reported on Form 4 | 1,019 | $266.2K | 2022-04-04 |
| 2022-04-08 | S, sale reported on Form 4 | 4,900 | $1.4M | 2022-04-12 |
| 2022-04-08 | S, sale reported on Form 4 | 100 | $28.1K | 2022-04-12 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1215126) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms